United States · FDA National Drug Code directory
Buprenorphine and Naloxone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-851_60f89242-ae36-4fe3-bd5c-8f34effd6534
- Product NDC
- 31722-851
- Form
- TABLET
- Composition / generic term
- Buprenorphine and Naloxone
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260105
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (31722-851-30) · 31722-851-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →